Iron Nation Fund II

Israel
Seed
Share

About Iron Nation Fund II

Iron Nation Fund II is a $60M fund ($50M already secured) with a $15M anchor from the State of Indiana. Invests seed to Series B in medtech, defense tech, deep tech, cybersecurity, and AI. Evolved from a $20.4M emergency fund launched after October 7, 2023. Early Nvidia exit via portfolio company Illumex.

Investment Focus

Location / RegionIsrael
Funding StageSeed
Industry Focus
Ai Ml
Cybersecurity
Deep Tech
Defense
Med Tech

Investor Signals Profile

active

Sweet Spot

Israeli post-PMF founder scaling physical AI/deep tech into US B2B

Israel-to-US expansion
Physical AI revolution
post-PMF deep tech scaling
seed to Series B
medtech & defense tech

Bullish Signals

Illumex acquired by Nvidia in March 2026, early DPI before Fund II closeblog
$50M of $60M target already secured at announcement in April 2026blog
State of Indiana anchors with $15M, providing real Eli Lilly and IU Health accessblog
24 Fund I companies deployed in 18 months shows strong deal velocityblog
27 investments, $75M AUM deployed with fast iteration cyclewebsite
Ranked #1 Israeli active investor in 2024external
Chemi Peres (Pitango) as Chairman adds institutional weightexternal
Ex-Congressman Luke Messer unlocks US policy accessexternal
Co-invests alongside premier VC funds — broad syndicate networkwebsite
Physical AI thesis explicit: health, food, energy, securitywebsite
Portfolio spans AI, medtech, defense, fintech, agtech, SaaSwebsite
Post-Oct 7 portfolio companies already showing strong tractionwebsite
Collaborative ecosystem fund model with Israeli institutional backingwebsite
Portfolio across cleantech, biotech, agtech solving global challengeswebsite
Purpose-driven: exceptional returns + Israel tech leadership missionwebsite

Contrarian Signals

Crowded Israeli Series A market with Viola, Bessemer, Lightspeed competingblog
US Midwest edge irrelevant for AI infrastructure and cybersecurity dealsblog
Not suitable for pre-seed or pre-revenue foundersblog
Wide vertical spread may dilute thesis focusexternal
Pro-Israel LP base = concentrated geopolitical LP riskwebsite
Geopolitical branding limits appeal beyond pro-Israel LPswebsite

Founder Do's

Show clear product-market fit and existing revenue before approaching
Highlight US Midwest expansion angle, especially Eli Lilly or IU Health relevance
Position for Series A or B readiness, not formation stage
Demonstrate Israeli origin with scalable US go-to-market plan
Lead with Physical AI angle: health, food, energy, security applications

Founder Don'ts

Pitch at pre-revenue or pre-seed stage — wrong fund for formation bets
Ignore Midwest angle and default to Bay Area expansion narrative
Approach without clear path to Series B within fund horizon

Key GPs & Partners

GF
Gil Friedlander
Managing Partner
ex-founderfast-moverthesis-driven
CL
Chen Linchevski
Managing Partner
ex-founderfast-moverhands-on
JW
Jason Wolf
Managing Partner
ex-founderthesis-drivencommunity-builder
CP
Chemi Peres
Chairman
institutional-VCsenior-advisorPitango-network
IS
Izhar Shay
IC Member
policy-connectedex-ministerdeep-tech
CF
Charlie Federman
IC Member
VC-partnerSilverTechco-invest-network
LM
Luke Messer
US Partner
policy-connectedex-congressmanUS-access
LAP
Lyat Avidor Peleg
Chief Marketing Officer
marketing-opsfounder-relationsbrand

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

Fund Overview

Fund Size$60M
Saves0

Key People

Gil Friedlander, Chen Linchevski, Jason Wolf

Gil FriedlanderManaging Partner
Chen LinchevskiManaging Partner
Jason WolfManaging Partner
Chemi PeresChairman
Izhar ShayIC Member
Charlie FedermanIC Member
Luke MesserUS Partner
Lyat Avidor PelegChief Marketing Officer

Related Funds

Protego Ventures I

$70M
Israel
Seed
Enterprise Software
Fund Manager:Lital Leshem
Seed
Enterprise Software

TBD VC Fund I

$35M
Israel
Pre Seed
Saas, Ai Ml
Fund Manager:David Citron, Alan Buch
Pre Seed
Saas
Ai Ml

Cyberstarts Seed Fund IV

$60M
Israel
Seed
Saas
Fund Manager:Gili Raanan, Lior Simon, Emily Heath
Seed
Saas